- Current report filing (8-K)
20 October 2011 - 8:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: October 13, 2011
MedQuist Holdings Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-35069
|
|
98-0676666
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
I.D. No.)
|
|
|
9009 Carothers Parkway
Franklin, Tennessee
|
|
37067
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(866) 295-4600
Registrants telephone number, including area code
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
Election of New Directors
On October 13, 2011, the Board of Directors (the Board) of MedQuist Holdings Inc. (the Company) increased the size of the
Board to eleven directors and elected, Robert J. Greczyn, Jr. and Andrew E. Vogel to the Board to fill the newly created directorships. The Board has not yet appointed Messrs. Greczyn or Vogel to any committees. There are no transactions in which
Messrs. Greczyn or Vogel have an interest requiring disclosure under Item 404(a) of Regulation S-K.
The Board has determined that each
of Mr. Greczyn and Mr. Vogel qualifies as an Independent Director as defined under NASDAQ Listing Rule 5605(a)(2) for all purposes under the rules and regulations of The NASDAQ Stock Market LLC. They will receive the standard
compensation for independent directors for service on the Board.
The full text of the press release issued in connection with the election is
attached hereto as Exhibit 99.1 and is incorporated by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Press Release Dated October 19, 2011
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
MedQuist Holdings Inc.
|
|
|
By
|
|
/s/ Mark R. Sullivan
|
Name:
|
|
Mark R. Sullivan
|
Title:
|
|
General Counsel & Chief Compliance Officer
|
Date: October 19, 2011
Exhibit Index
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Press Release October 19, 2011
|
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Medx Holdings Inc (CE) (OTCMarkets): 0 recent articles
More News Articles